ZBH · Zimmer Biomet Holdings, Inc. · Insider Trading

Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

Each RSU represents a contingent right to receive one share of Company common stock.

Each RSU represents a contingent right to receive one share of Company common stock.

One-third of these RSUs vested on October 1, 2026. The remaining RSUs vest one-half on October 1, 2027 and one-half on October 1, 2028.

Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Includes 7.276 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

Includes 49.652 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

Includes 32.614 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Includes 17.252 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

Includes 96.739 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Includes 9.178 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

Includes 85.331 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Includes 471 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through July 31, 2026.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

One-third of the RSUs shall vest on each of August 3, 2027, August 3, 2028 and August 3, 2029.

Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

Each RSU represents a contingent right to receive one share of Company common stock.

One-third of the RSUs vested on August 1, 2026. The remaining RSUs vest one-half on each of August 1, 2027 and August 1, 2028.

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

Each RSU represents a contingent right to receive one share of Company common stock.

Vests annually over three years in increments of one-third each year, commencing June 1, 2027.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Includes 34.300 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Includes 60.604 phantom stock units accrued on April 30, 2026, 57.375 phantom stock units accrued on January 30, 2026, 49.323 phantom stock units accrued on October 31, 2025 and 53.221 phantom stock units accrued on July 31, 2025, in each case under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director

Includes 21.697 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Includes 16.937 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Includes 106.777 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Includes 93.883 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as of a Director or (2) the date that is three years after the grant date.

Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination as a Director or (2) the date that is three years after the grant date.

Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Includes 7.812 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Includes 5.662 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Includes 53.557 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

The Conversion or Exercise Price of Derivative Security is 1-for-1.

The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.

Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock.

Vests annually over three years in increments of one-third each year, commencing on May 1, 2027.

Each RSU represents a contingent right to receive one share of Company common stock.

One-third of the RSUs vested on April 1, 2026. The remaining RSUs vest one-half on each of April 1, 2027 and April 1, 2028.

Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding on the vesting of restricted stock units ("RSUs").